| The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease NM El-Sayed, PJ Myler, DC Bartholomeu, D Nilsson, G Aggarwal, ... Science 309 (5733), 409-415, 2005 | 1792 | 2005 |
| Kinetoplastids: related protozoan pathogens, different diseases K Stuart, R Brun, S Croft, A Fairlamb, RE Gürtler, J McKerrow, S Reed, ... The Journal of clinical investigation 118 (4), 1301-1310, 2008 | 727 | 2008 |
| The Trypanosoma cruzi Proteome JA Atwood III, DB Weatherly, TA Minning, B Bundy, C Cavola, ... Science 309 (5733), 473-476, 2005 | 503 | 2005 |
| Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection RL Tarleton, BH Koller, A Latour, M Postan Nature 356 (6367), 338-340, 1992 | 416 | 1992 |
| Parasite persistence in the aetiology of Chagas disease RL Tarleton International journal for parasitology 31 (5-6), 550-554, 2001 | 411 | 2001 |
| Parasite persistence correlates with disease severity and localization in chronic Chagas' disease L Zhang, RL Tarleton The Journal of infectious diseases 180 (2), 480-486, 1999 | 374 | 1999 |
| Chagas disease etiology: autoimmunity or parasite persistence? RL Tarleton, L Zhang Parasitology today 15 (3), 94-99, 1999 | 308 | 1999 |
| Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. RL Tarleton Journal of immunology (Baltimore, Md.: 1950) 144 (2), 717-724, 1990 | 307 | 1990 |
| Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR KL Cummings, RL Tarleton Molecular and biochemical parasitology 129 (1), 53-59, 2003 | 300 | 2003 |
| The challenges of Chagas disease—grim outlook or glimmer of hope? RL Tarleton, R Reithinger, JA Urbina, U Kitron, RE Gürtler PLoS medicine 4 (12), e332, 2007 | 283 | 2007 |
| Immune system recognition of Trypanosoma cruzi RL Tarleton Current opinion in immunology 19 (4), 430-434, 2007 | 266 | 2007 |
| CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes DL Martin, DB Weatherly, SA Laucella, MA Cabinian, MT Crim, S Sullivan, ... PLoS pathogens 2 (8), e77, 2006 | 263 | 2006 |
| A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results DB Weatherly, JA Atwood, TA Minning, C Cavola, RL Tarleton, R Orlando Molecular & Cellular Proteomics 4 (6), 762-772, 2005 | 254 | 2005 |
| Frequency of Interferon-γ-Producing T Cells Specific for Trypanosoma cruzi Inversely Correlates with Disease Severity in Chronic Human Chagas Disease SA Laucella, M Postan, D Martin, BH Fralish, MC Albareda, MG Alvarez, ... Journal of Infectious Diseases 189 (5), 909-918, 2004 | 238 | 2004 |
| Chagas disease: a role for autoimmunity? RL Tarleton Trends in parasitology 19 (10), 447-451, 2003 | 237 | 2003 |
| EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens D Peng, R Tarleton Microbial genomics 1 (4), e000033, 2015 | 230 | 2015 |
| Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease JM Bustamante, LM Bixby, RL Tarleton Nature medicine 14 (5), 542-550, 2008 | 221 | 2008 |
| Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease RL Tarleton, J Sun, L Zhang, M Postan Infection and immunity 62 (5), 1820-1829, 1994 | 220 | 1994 |
| Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure FJ Sánchez-Valdéz, A Padilla, W Wang, D Orr, RL Tarleton Elife 7, e34039, 2018 | 218 | 2018 |
| Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I-and class II-restricted T cells in immune resistance and disease RL Tarleton, MJ Grusby, M Postan, LH Glimcher International immunology 8 (1), 13-22, 1996 | 217 | 1996 |
